TP53 and esophageal cancer: Thus, loss of function p53 mutations may result in escape of post-mitotic G1 cell cycle control and possibly also centrosomal dysfunction [41-45] in some (OE21, OE33), but not all (Kyse-410, OE19) esophageal cancer cells.